Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin, cytoplasmic 1 (encoded by the ACTB gene, commonly known as β-actin), is a highly conserved, abundant structural protein ubiquitously expressed in all eukaryotic cells[1][4][6][7]. It dynamically assembles into filaments (F-actin) and exists in a monomeric form (G-actin), forming the core of the cytoskeleton and participating in various essential cellular processes including maintenance of cell shape, cell motility, cell division (cytokinesis), chromatin remodeling, and regulation of gene expression[1][2][4][5][8]. Actin filaments interact with numerous actin-binding proteins, affecting key cellular activities and acting as hubs for complex intracellular signaling and structure[2][3][4]. Mutations in ACTB can cause human disease, including developmental syndromes and have secondary roles in cancer cell biology[8]. Actin is not typically considered a classical therapeutic target due to its essential and conserved functions, but it is extensively used as a cellular marker and research tool[1][4]. Several toxins and research drugs bind actin, interfering with filament dynamics (e.g., cytochalasin D, phalloidin), but their clinical utility is limited by toxicity and a lack of cell-type specificity[4].
Polymerization inhibition or stabilization (for actin inhibitors/stabilizers); Disruption of actin filaments influencing cell motility, morphology, and division
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin, cytoplasmic 1 (ACTB).